Adnavance Technologies, Inc.
Nanotechnology company secures Series A financing totaling $3.85M
Published in Lab Business Week, January 1st, 2006
Combining biotechnology and nanotechnology, Adnavance is developing product applications that use the electrical conductivity properties of both DNA and novel metallic forms of DNA (M-DNA), for the healthcare and nanotechnology industries.
Adnavance has also secured substantial non-dilutive funding from The National Research Council's Industrial Research Assistance Program (NRC-IRAP) and from The Natural Sciences and Engineering Research Council of Canada (NSERC), to support its research and development programs.
"This is a significant...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-01-01)
More Articles from Lab Business Week
- AXM Pharma, Inc.
Generic drug maker for Asian markets files form 10-Q for third quarter - Advanced BioHealing, Inc.
Tissue preservation technology developer closes $8M financing - Aegis Analytical Corp.
Pharmaceutical IT company closes $3.5M equity funding and announces new appointment - Aldagen, Inc.
StemCo Biomedical changes name to reflects focus in regenerative medicine - Alfacell Corp.
Cancer drug maker launches new investor relations section on website - Alimera Sciences, Inc.
Ophthalmic pharmaceutical company secures $31.8M in series B financing - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
